期刊文献+

Expanding mTOR signaling 被引量:52

Expanding mTOR signaling
下载PDF
导出
摘要 The mammalian target of rapamycin (mTOR) has drawn growth control and its involvement in human tumorigenesis much attention recently because of its essential role in cell Great endeavors have been made to elucidate the functions and regulation of mTOR in the past decade. The current prevailing view is that mTOR regulates many fundamental biological processes, such as cell growth and survival, by integrating both intracellular and extracellular signals, including growth factors, nutrients, energy levels, and cellular stress. The significance of roTOR has been highlighted most recently by the identification of mTOR-associated proteins. Amazingly, when bound to different proteins, mTOR forms distinctive complexes with very different physiological functions. These findings not only expand the roles that mTOR plays in cells but also further complicate the regulation network. Thus, it is now even more critical that we precisely understand the underlying molecular mechanisms in order to directly guide the development and usage of anti-cancer drugs targeting the mTOR signaling pathway. In this review, we will discuss different mTOR-associated proteins, the regulation of mTOR complexes, and the consequences of mTOR dysregulation under pathophysiological conditions.
作者 Qian Yang
出处 《Cell Research》 SCIE CAS CSCD 2007年第8期666-681,共16页 细胞研究(英文版)
关键词 MTOR RAPAMYCIN S6K1 Akt cancer OBESITY DIABETES 雷帕霉素 肿瘤 糖尿病 细胞信号
  • 相关文献

参考文献136

  • 1Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773- 1780. 被引量:1
  • 2Moses JW, Leon MB, Popma JJ, etal. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323. 被引量:1
  • 3Marks AR. Sirolimus for the prevention of in-stent restenosis in a coronary artery. N Engl J Med 2003; 349:1307-1309. 被引量:1
  • 4Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991; 253:905-909. 被引量:1
  • 5Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 1993; 73:585-596. 被引量:1
  • 6Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989; 341:758-760. 被引量:1
  • 7Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341:755-757. 被引量:1
  • 8Siekierka J J, Wiederrecht G, Greulich H, et al. The cytosolicbinding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. J Biol Chem 1990; 265:21011-21015. 被引量:1
  • 9Brown EJ, Albers MW, Shin TB, et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994; 369:756-758. 被引量:1
  • 10Chiu MI, Katz H, Berlin V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP 12/rapamycin complex. Proc Natl Acad Sci USA 1994; 91:12574-12578. 被引量:1

同被引文献132

引证文献52

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部